» Articles » PMID: 10023616

HIV-risk Behaviors in Adolescent Substance Abusers

Overview
Specialty Psychiatry
Date 1999 Feb 19
PMID 10023616
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty adolescents aged 12-18 years from each group (substance use disorders, psychiatric disorders, and controls) were assessed to explore HIV-risk behaviors and knowledge about HIV/AIDS. Semi-structured instruments for psychiatric and substance use disorders were also administered. There were no significant differences between groups in knowledge of HIV/AIDS. However, chi-square analysis of risk behaviors revealed significant differences between the substance use disorders group and the controls. The knowledge-behavior gap was greater for the substance users than all other groups, in that while they knew an equal amount about HIV/AIDS, they actually engaged in more risky sexual behaviors than the other two groups. It may be that the impulsivity associated with substance use disorders accounts for this difference. It is recommended that HIV/AIDS prevention education and impulse control strategies are included in the treatment of adolescents with substance use disorders.

Citing Articles

A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.

Marsch L, Moore S, Borodovsky J, Solhkhah R, Badger G, Semino S Addiction. 2016; 111(8):1406-15.

PMID: 26918564 PMC: 4940230. DOI: 10.1111/add.13363.


Risky Sexual Behavior and Substance Use among Adolescents: A Meta-analysis.

Ritchwood T, Ford H, DeCoster J, Sutton M, Lochman J Child Youth Serv Rev. 2015; 52:74-88.

PMID: 25825550 PMC: 4375751. DOI: 10.1016/j.childyouth.2015.03.005.


Prevalence and predictors of injection drug use and risky sexual behaviors among adolescents in substance treatment.

Thurstone C, Salomonsen-Sautel S, Mikulich-Gilbertson S, Hartman C, Sakai J, Hoffenberg A Am J Addict. 2013; 22(6):558-65.

PMID: 24131163 PMC: 3931469. DOI: 10.1111/j.1521-0391.2013.12064.x.


Affect regulation and HIV risk among youth in therapeutic schools.

Brown L, Houck C, Lescano C, Donenberg G, Tolou-Shams M, Mello J AIDS Behav. 2012; 16(8):2272-8.

PMID: 22669595 PMC: 3496428. DOI: 10.1007/s10461-012-0220-3.


Amphetamine use and its associated factors in body builders: a study from Tehran, Iran.

Angoorani H, Narenjiha H, Tayyebi B, Ghassabian A, Ahmadi G, Assari S Arch Med Sci. 2012; 8(2):362-7.

PMID: 22662012 PMC: 3361051. DOI: 10.5114/aoms.2012.28566.